| Home Market Dynamics Macro Trends Sector Trends Company Insights AI Investing Strategies Sign Up Login |
Sector: Pharmaceuticals
| Eli Lilly has demonstrated significant advancements in product development, particularly in the treatment of Crohn's disease and obesity. The strong long-term efficacy data and the successful launch of new formulations indicate a positive trajectory for their products. Achievements such as outperforming competitors in the obesity drug market further reinforce the company's innovative approach and market positioning. Overall, these factors suggest a robust outlook for Eli Lilly's continued growth in delivering impactful therapies. |
| The price action of Eli Lilly (LLY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at 0.1 is modestly bullish. The market sentiment at 0.5 is modestly bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next. LLY is likely to move up since both trend sentiment and market sentiment are positive. The positive sentiment force for sector is at 0.7, and the negative at -0.2 on 2026-02-25. The forces of Sentiment towards Fundamentals (3.3), Option Sentiment (0.8), Market Risk Appetite (0.1), Stock Price Trend (0.1), and Price Level Sentiment (0) will drive up the price. The forces of Sector Price Trend (-0.1), and Valuation Sentiment (-1) will drive down the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
Sign up to reveice notifications on Market Movers
| LLY | ||||||||||||||
| Date | Attention | Price | StdDev | Price Level | Change | 10 Day Trend | Trend Sentiment | Hourly Trend Sentiment | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-25 | 0%(0%) | 1029.1 | 2.14% | 43 | -1.33% | 0.04% | 0.1 | -0.5 | 0.9% | 0.5 | Short | 55% | 3.3 | 7 |
| 2026-02-24 | 0%(0%) | 1042.93 | 2.11% | 58 | -1.46% | -0.02% | 0 | -0.2 | 1.5% | -0.2 | Short | 55% | 3 | -1 |
| 2026-02-23 | 0%(0%) | 1058.41 | 2.14% | 74 | 4.83% | 0.01% | 0.4 | 0.7 | 1.7% | 0.1 | Long | 55% | 3.4 | 4.5 |
| 2026-02-22 | 0%(0%) | -1.1 | 0.7 | 0.3 | 4.6 | -1 | ||||||||
| 2026-02-21 | 0%(0%) | -1.1 | 0.7 | 0.3 | 4.6 | -1 | ||||||||
| 2026-02-20 | 0%(0%) | 1009.69 | 2.28% | 21 | -1.33% | -0.11% | -1.1 | -0.2 | 0.5% | 0.6 | Short | 55% | 4.8 | -1 |
| 2026-02-19 | 0%(0%) | 1023.26 | 2.41% | 32 | 0.28% | -0.81% | -0.9 | 0.1 | 1% | 0.1 | Wait | 50% | 4.5 | -1 |
| 2026-02-18 | 0%(0%) | 1020.37 | 2.51% | 27 | -1.55% | 0.16% | 0 | -0.3 | 1.3% | 0.2 | Short | 55% | 4.3 | -1 |
| 2026-02-17 | 0%(0%) | 1036.44 | 2.41% | 42 | -0.36% | -0.07% | -0.3 | -0.4 | 0.4% | 0.4 | Short | 55% | 4.7 | 7 |
| 2026-02-16 | 0%(0%) | -0.3 | -0.4 | -0.1 | 4.5 | -1 | ||||||||
| Short is the preferred trading strategy with 55% chance of being right. Weak trend sentiment and negative hourly trend. Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | ||||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | ||||||||||||||
| 2026-02-25 17:01:59 The general recovery in stock indices indicates potential positive momentum for companies, including Eli Lilly, after recent downturns. |
| 2026-02-25 17:01:59 Analyst research calls impact investor decisions, contributing to stock market fluctuations, as seen in recent trends. |
| 2026-02-25 17:01:59 Despite current market volatility, Eli Lilly is viewed as a strong growth stock essential for long-term investment strategies. |
| 2026-02-25 17:01:59 Recent stock price movements reflect broader market conditions and investor sentiment, including a slight decline in Eli Lilly's stock. |
| 2026-02-25 17:01:59 Eli Lilly's stock performance is affected by price cuts from competitors, indicating a competitive pressure in the pharmaceutical market. |
| 2026-02-25 15:49:41 The advancements by Eli Lilly in the obesity drug sector underline the company's efforts in developing competitive products. |
| 2026-02-25 15:49:41 Eli Lilly's revenue and earnings have significantly increased, indicating strong financial performance. |
| 2026-02-25 11:49:22 JPMorgan's analysis indicates a positive outlook for Eli Lilly as a leading player in the obesity drug sector, reflecting confidence from market analysts. |
| 2026-02-25 11:49:22 Eli Lilly's designation as 'best-in-class' suggests strong competitive advantages as the demand for GLP-1 medication rises, positioning the company favorably in the industry. |
| 2026-02-25 11:49:22 The increasing trend of direct-to-consumer sales for obesity drugs is seen as a significant growth opportunity, particularly for companies like Eli Lilly recognized for their strong position in this market. |